Cargando…
Anti-schistosomal immunity to core xylose/fucose in N-glycans
Schistosomiasis is a globally prevalent, debilitating disease that is poorly controlled by chemotherapy and for which no vaccine exists. While partial resistance in people may develop over time with repeated infections and treatments, some animals, including the brown rat (Rattus norvegicus), are on...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110957/ https://www.ncbi.nlm.nih.gov/pubmed/37081851 http://dx.doi.org/10.3389/fmolb.2023.1142620 |
_version_ | 1785027357701046272 |
---|---|
author | Prasanphanich, Nina Salinger Leon, Kristoffer Secor, W. Evan Shoemaker, Charles B. Heimburg-Molinaro, Jamie Cummings, Richard D. |
author_facet | Prasanphanich, Nina Salinger Leon, Kristoffer Secor, W. Evan Shoemaker, Charles B. Heimburg-Molinaro, Jamie Cummings, Richard D. |
author_sort | Prasanphanich, Nina Salinger |
collection | PubMed |
description | Schistosomiasis is a globally prevalent, debilitating disease that is poorly controlled by chemotherapy and for which no vaccine exists. While partial resistance in people may develop over time with repeated infections and treatments, some animals, including the brown rat (Rattus norvegicus), are only semi-permissive and have natural protection. To understand the basis of this protection, we explored the nature of the immune response in the brown rat to infection by Schistosoma mansoni. Infection leads to production of IgG to parasite glycoproteins with complex-type N-glycans that contain a non-mammalian-type modification by core α2-Xylose and core α3-Fucose (core Xyl/Fuc). These epitopes are expressed on the surfaces of schistosomula and adult worms. Importantly, IgG to these epitopes can kill schistosomula by a complement-dependent process in vitro. Additionally, sera from both infected rhesus monkey and infected brown rat were capable of killing schistosomula in a manner inhibited by glycopeptides containing core Xyl/Fuc. These results demonstrate that protective antibodies to schistosome infections in brown rats and rhesus monkeys include IgG responses to the core Xyl/Fuc epitopes in surface-expressed N-glycans, and raise the potential of novel glyco-based vaccines that might be developed to combat this disease. |
format | Online Article Text |
id | pubmed-10110957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101109572023-04-19 Anti-schistosomal immunity to core xylose/fucose in N-glycans Prasanphanich, Nina Salinger Leon, Kristoffer Secor, W. Evan Shoemaker, Charles B. Heimburg-Molinaro, Jamie Cummings, Richard D. Front Mol Biosci Molecular Biosciences Schistosomiasis is a globally prevalent, debilitating disease that is poorly controlled by chemotherapy and for which no vaccine exists. While partial resistance in people may develop over time with repeated infections and treatments, some animals, including the brown rat (Rattus norvegicus), are only semi-permissive and have natural protection. To understand the basis of this protection, we explored the nature of the immune response in the brown rat to infection by Schistosoma mansoni. Infection leads to production of IgG to parasite glycoproteins with complex-type N-glycans that contain a non-mammalian-type modification by core α2-Xylose and core α3-Fucose (core Xyl/Fuc). These epitopes are expressed on the surfaces of schistosomula and adult worms. Importantly, IgG to these epitopes can kill schistosomula by a complement-dependent process in vitro. Additionally, sera from both infected rhesus monkey and infected brown rat were capable of killing schistosomula in a manner inhibited by glycopeptides containing core Xyl/Fuc. These results demonstrate that protective antibodies to schistosome infections in brown rats and rhesus monkeys include IgG responses to the core Xyl/Fuc epitopes in surface-expressed N-glycans, and raise the potential of novel glyco-based vaccines that might be developed to combat this disease. Frontiers Media S.A. 2023-04-04 /pmc/articles/PMC10110957/ /pubmed/37081851 http://dx.doi.org/10.3389/fmolb.2023.1142620 Text en Copyright © 2023 Prasanphanich, Leon, Secor, Shoemaker, Heimburg-Molinaro and Cummings. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Prasanphanich, Nina Salinger Leon, Kristoffer Secor, W. Evan Shoemaker, Charles B. Heimburg-Molinaro, Jamie Cummings, Richard D. Anti-schistosomal immunity to core xylose/fucose in N-glycans |
title | Anti-schistosomal immunity to core xylose/fucose in N-glycans |
title_full | Anti-schistosomal immunity to core xylose/fucose in N-glycans |
title_fullStr | Anti-schistosomal immunity to core xylose/fucose in N-glycans |
title_full_unstemmed | Anti-schistosomal immunity to core xylose/fucose in N-glycans |
title_short | Anti-schistosomal immunity to core xylose/fucose in N-glycans |
title_sort | anti-schistosomal immunity to core xylose/fucose in n-glycans |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110957/ https://www.ncbi.nlm.nih.gov/pubmed/37081851 http://dx.doi.org/10.3389/fmolb.2023.1142620 |
work_keys_str_mv | AT prasanphanichninasalinger antischistosomalimmunitytocorexylosefucoseinnglycans AT leonkristoffer antischistosomalimmunitytocorexylosefucoseinnglycans AT secorwevan antischistosomalimmunitytocorexylosefucoseinnglycans AT shoemakercharlesb antischistosomalimmunitytocorexylosefucoseinnglycans AT heimburgmolinarojamie antischistosomalimmunitytocorexylosefucoseinnglycans AT cummingsrichardd antischistosomalimmunitytocorexylosefucoseinnglycans |